Alzheimer’s Research UK is leading the way finding new treatments, and has recently launched a range of initiatives – including pioneering Drug Discovery Institutes and a Global Clinical Trials Fund – to bring new treatments to patients sooner. The charity has welcomed the Government’s announcement, which comes a year after the UK used its presidency of the G8 to hold the first Dementia Summit to find ways to tackle the condition. The summit saw the G8 countries commit to an aim to find a disease-modifying treatment by 2025.
Hilary Evans, Director of External Affairs at Alzheimer's Research UK, the UK’s leading dementia research charity, said:
"Alzheimer's Research UK welcomes today's announcement of extra investment in research, this represents another step forward in the fight to tackle what is our greatest health challenge and a devastating condition. The treatments available for people with dementia offer scant relief and are simply not good enough – we need a therapy that acts to slow or stop disease in its tracks. If we could produce a treatment that delayed onset by five years, a third fewer people would ever experience the devastation of dementia.
“The new funds complement Alzheimer's Research UK's own major investment in dementia drug discovery and our efforts to end the tortuous wait for an effective treatment that people deserve."
____________________________________________